首页> 美国卫生研究院文献>Blood research >A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia
【2h】

A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia

机译:抗人白细胞抗原抗体诱发急性白血病与输血相关的急性肺损伤一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transfusion-related acute lung injury (TRALI) is a noncardiogenic pulmonary edema that occurs during or within 6 hours after transfusion. Risk factors for TRALI, which is relatively common in critically ill patients, include recent surgery, hematologic malignancy, and sepsis. Here, we report a case of TRALI induced by anti-human leukocyte antigen (anti-HLA) class II antibodies (HLA-DR) occurring after transfusion of platelet concentrates in a patient with acute leukemia. Although most patients with TRALI show improvement within 48-96 hours, our patient's condition rapidly worsened, and he did not respond to supportive treatment. TRALI is a relatively common and serious adverse transfusion reaction that requires prompt diagnosis and management.
机译:与输血有关的急性肺损伤(TRALI)是一种非心源性肺水肿,发生在输血期间或输血后6小时之内。在重症患者中相对常见的TRALI危险因素包括近期手术,血液系统恶性肿瘤和败血症。在这里,我们报道了在急性白血病患者中输注浓缩血小板后发生的由抗人类白细胞抗原(抗HLA)II类抗体(HLA-DR)诱导的TRALI病例。尽管大多数TRALI患者在48-96小时内显示出改善,但我们患者的病情迅速恶化,并且他对支持治疗没有反应。 TRALI是一种相对普遍和严重的不良输血反应,需要及时诊断和处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号